Novel CD8+ cytotoxic T cell epitopes in bovine leukemia virus with cattle

Vaccine

Volumn 33, Issue 51, 2015, Pages 7194-7202

  Bai, Lanlan ^a,b   Takeshima, Shin nosuke ^a   Isogai, Emiko ^b   Kohara, Junko ^c   Aida, Yoko ^a  

^a RIKEN   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c HOKKAIDO RESEARCH ORGANIZATION   (Japan)

Author keywords

Bovine leukemia virus; Bovine MHC class I; CD8+ CTL epitope mapping; CD8+ T cell proliferation; Cytotoxicity; Experimentally infected calves

Indexed keywords

EPITOPE; GAG PROTEIN; GP30 PROTEIN; GP51 PROTEIN; MITOMYCIN; PROTEIN P12; PROTEIN P15; PROTEIN TYROSINE PHOSPHATASE SHP 1; TAX PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE ACTIVATION; BOVINE LEUKEMIA VIRUS; BOVINE LEUKEMIA VIRUS INFECTION; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY ASSAY; DELTARETROVIRUS INFECTION; EPITOPE MAPPING; IMMUNORECEPTOR TYROSINE BASED INHIBITION MOTIF; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; VIRUS LOAD; WST-8 ASSAY; ANIMAL; BOVINE; CYTOTOXICITY TEST; ENZOOTIC BOVINE LEUKOSIS; IMMUNOLOGY;

ANIMALS; CATTLE; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY TESTS, IMMUNOLOGIC; ENZOOTIC BOVINE LEUKOSIS; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENE PRODUCTS, TAX; LEUKEMIA VIRUS, BOVINE;

EID: 84951970570     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.10.128     Document Type: Article

References (46)

1. Gillet N.A., Florins M., Boxus C., Burteau A., Nigro F., Vandermeers H., et al. Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology 2007, 4:18.
2. Aida Y., Murakami H., Takahashi M., Takeshima S.N. Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus. Front Microbiol 2013, 4:328.
3. Sagata N., Yasunaga Y., Ohishi K., Tsuzuku-Kawamura J., Onuma M., Ikawa Y. Comparison of the entire genomes of bovine leukemia virus and human T-cell leukemia virus and characterization of their unidentified open reading frames. EMBO J 1984, 3:3231-3237.
4. Hamard-Peron E., Muriaux D. Retroviral matrix and lipids, the intimate interaction. Retrovirology 2011, 8:15.
5. Voneche V., Portetelle D., Kettmann R., Willems L., Limbach K., Paoletti E., et al. Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells. Proc Natl Acad Sci U. S. A. 1992, 89:3810-3814.
6. Derse D. Bovine leukemia virus transcription is controlled by a virus encoded trans-acting factor and by cis-acting response elements. J Virol 1987, 61:2462-2471.
7. Willems L., Gegonne A., Chen G., Burny A., Kettmann R., Ghysdael J. The bovine leukemia virus p34 is a transactivator protein. EMBO J 1987, 6:3385-3389.
8. Haraguchi S., Good R.A., Day N.K. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol Today 1995, 16:595-603.
9. Elemans M., Florins A., Willems L., Asquith B. Rates of CTL killing in persistent viral infection in vivo. PoLS Comput Biol 2014, 1003534. 10.1371/journal.pcbi.
10. Yoko A., Takeshima S.N., Cynthia L.B., Azad K.K. Bovine immunogenetics. The genetics of cattle 2015, 153-191. CBAI, London, UK. J.G. Dorian, R. Anatoly (Eds.).
11. Takeshima S.N., Aida Y. Structure, function and disease susceptibility of the bovine major histocompatibility complex. Anim Sci J 2006, 77:138-150.
12. Madden D.R. The three-dimensional structure of peptide-MHC complexes. Ann Rev Immunol 1995, 13:587-622.
13. Yewdell J.W., Bennink J.R. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Ann Rev Immunol 1999, 17:51-88.
14. Kabeya H., Ohashi K., Ohishit K., Sugimoto C., Amanumat H., Onuma M. An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep. Vaccine 1996, 14:1118-1122.
15. Callebaut I., Voneche V., Mager A., Fumiere O., Krchnak V., Merza M., et al. Mapping of B-neutralizing and T-helper cell epitopes on the bovine leukemia virus external glycoprotein gp51. J Virol 1993, 67:5321-5327.
16. +T cells in response to gag- and env-encoded BLV proteins. J Virol 1996, 70:7584-7593.
17. Ohishi K., Suzuki H., Yamamoto T., Maruyama T., Mild K., Ikawa Y., et al. Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: association with cell-mediated immunity. J Gen Virol 1991, 72:1887-1892.
18. Ohishi K., Suzuki H., Yasutomi Y., Onuma M., Okada K., Numakunai S., et al. Augmentation of bovine leukemia virus (BLV)-specific lymphocyte proliferation responses in ruminants by inoculation with BLV env-recombinant vaccina virus: their role in the suppression of BLV replication. Microbiol Immunol 1992, 30:1317-1323.
19. Onuma M., Hodatsu T., Yamamoto S., Higashihara M., Masu S., Mikami T., et al. Protection by vaccination against bovine leukemia virus infection in sheep. Am J Vet Res 1984, 45:1212-1215.
20. Sakakibara N., Kabeya H., Ohashi K., Sugimoto C., Onuma M. Epitope mapping of bovine leukemia virus transactivator protein Tax. J Vet Med 1998, 60:599-605.
21. Kabeya H., Ohashi K., Sugimoto C., Onuma M Bovine leukaemia virus envelope peptides cause immunomodulation in BALB/c mice. Vet Immunol Immunopathol 1999, 68:39-48.
22. Gatei M.H., Good M.F., Daniel R.C., Lavin M.F. T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development. J Virol 1993, 67:1796-1802.
23. Jimba M., Takeshima S.N., Murakami H., Kohara J., Kobayashi N., Matsuhashi T., et al. BLV-CoCoMo-qPCR: a useful tool for evaluating bovine leukemia virus infection status. BMC Vet Res 2012, 8:167-179.
24. Jimba M., Takeshima S.N., Matoba K., Endoh D., Aida Y. BLV-CoCoMo-qPCR: quantitation of bovine leukemia virus proviral load using the CoCoMo algorithm. Retrovirology 2010, 7:91-110.
25. Polat M., Ohno A., Takeshima S.N., Kim J., Kikuya M., Matsumoto Y., et al. Detection and molecular characterization of bovine leukemia virus in Philippine cattle. Arch Virol 2015, 160:285-296.
26. Takeshima S.N., Kitamura-Muramatsu Y., Yuan Y., Saito S., Aida Y. BLV-CoCoMo-qPCR-2: improvements to the BLV-CoCoMo-qPCR by reducing primer degeneracy and constructing an optimal standard curve. Arch Virol 2015, 160:1325-1332.
27. Miyasaka M., Zdenek T. Sheep as an experimental model for immunology: immunological techniques in vitro and in vivo. Immunol Methods 1985, 3:403-422.
28. Wu T.T., Kabat E.A. An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med 1970, 132:211-250.
29. Portetelle D., Dandoy C., Burny A., Zavada J., Siakkou H., Gras-Masse H., et al. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51. Virology 1989, 169:34-41.
30. Hamilton V.T., Stone D.M., Pritchard S.M., Cantor G.H. Bovine leukemia virus gp30 transmembrane (TM) protein is not tyrosine phosphorylated: examining potential interactions with host tyrosine-mediated signaling. Virus Res 2002, 90:155-169.
31. Willems L., Kettmann R., Burny A. The amino acid (157-197) peptide segment of bovine leukemia virus p34 tax encompass a leucine-rich globally neutral activation domain. Oncogene 1991, 6:159-163.
32. Ren R., Mayer B.J., Cicchetti P., Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science 1993, 259:1157-1161.
33. Hollsberg P., Weber W.E., Dangond F., Batra V., Sette A., Hafler D.A. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax specific CD8T cells by an altered peptide ligand. Proc Natl Acad Sci USA 1995, 92:4036-4040.
34. Kannagi M., Shida H., Igarashi H., Kuruma K., Murai H., Aono Y., et al. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J Virol 1992, 66:2928-2933.
35. Koenig S., Woods R.M., Brewah Y.A., Newell A.J., Jones G.M., Boone E., et al. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. J Immunol 1993, 151:3874-3883.
36. Niewiesk S., Daenke S., Parker C.E., Taylor G., Weber J., Nightingale S., et al. Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J Virol 1995, 69:2649-2653.
37. Parker C.E., Nightingale S., Taylor G.P., Weber J., Bangham C.R. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J Virol 1994, 68:2860-2868.
38. Pique C., Connan F., Levilain J.P., Choppin J., Dokhelar M.C. Among all human T-cell leukemia virus type I proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response. J Virol 1996, 70:4919-4926.
39. Jacobson S., Shida H., McFarlin D.E., Fauci A.S., Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature (Lond) 1990, 348:245-248.
40. + cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol 1991, 3:761-767.
41. Parker C.E., Daenke S., Nightingale S., Bangham C.R., Activated HTLV-I-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992, 188:628-636.
42. Johnston E.R., Radke K. The S.U.T.M. envelope protein subunits of bovine leukemia virus are linked by disulfide bonds, both in cells and in virions. J Virol 2000, 74:2930-2935.
43. Kettmann R., Burny A., Callebaut I., Droogmans L., Mammerickx M., Willems L., et al. Bovine leukemia virus. Retrovir 1994, 3:39-81.
44. Hojnik M., Dobovisek L., Knez Z., Ferk P. A synergistic interaction of 17-beta-estradiol with specific cannabinoid receptor type 2 antagonist/inverse agonist on proliferation activity in primary human osteoblasts. Biomed Rep 2015, 3:554-558.
45. Cantor G.H., Pritchard S.M., Orlik O., Splitter G.A., Davis W.C. Bovine leukemia virus transmembrane protein gp30 physically associates with the down-regulatory phosphatase SHP-1. Cell Immunol 1999, 193:117-124.
46. Mustafa A.S. Characterization of a cross-reactive, immunodominant and HLA-promiscuous epitope of Mycobacterium tuberculosis-specific major antigenic protein PPE68. PloS One 2014, 9:e103679.